CHRTlines

Recent Posts

01/23/2012 Federal Health Research Cuts: You Can’t Have it Both Ways

01/09/2012 The Latest (Not Greatest) on Essential Benefits

12/19/2011 Complexity and Confusion: The Challenge of Communicating About the Affordable Care Act

Browse by Date

Tag Cloud

health reform essential benefits costs health policy aca reform coverage cost sgr politics congress drugs class long term care quality va employers e-prescribing emrs patient safety medicaid states medicare for-profit nonprofit block grant tanf welfare reform hospice end of life non-profit evidence-based care waste washtenaw county uninsured acos population health managed care cms access cancer end-of-life care individual mandate ryan proposal obesity pharmaceutical industry r & d comparative effectiveness research evidence based care quality improvement collaborative quality initiatives cqi pharmaceuticals regulations prematurity exchanges heath reform antibiotics overuse geographic variation medical appropriateness health websites imrt radiation therapy medical errors constitutionality courts research translate health care economics rationing insurance regulation incentives cardiology pcmh health disparities election british health care system safety net fqhc guidelines variation radiology pain early childhood electronic medical records physician employment aco dartmouth atlas cover michigan health care coverage insurance preventive care public health

Viewing entries tagged with 'public health'

View all posts »

And Now for a Message about Public Health

Marianne Udow-Phillips

Posted by Marianne Udow-Phillips on April 5, 2010

With all the focus this past week on health care reform with a capital “H” (and a really boring official name, The Patient Protection and Affordable Care Act), a very important development relating to the public’s health could easily have been missed: a seminal ruling by New York federal court judge Robert Sweet. Judge Sweet’s March 29, 2010 ruling invalidates gene patents held by Myriad Genetics on the BRAC1 and BRAC2 genes. While the front pages of newspapers (and whole sections, in fact) were focused on the details of health reform, the gene patent story was, for the most part, found in the business pages or buried somewhere in the middle (except, of course, for journals catering to the biotech industry where headlines like “Pigs Can Fly” abounded). And, yet, this ruling is one the public should really pay attention to because it could have a profound impact on our health: now and into the future.

Read full post »
0 comments »

Tags: